Literature DB >> 6259084

Reversible inhibition of cytomegalovirus replication by phosphonoformate.

B Wahren, B Oberg.   

Abstract

Cytomegalovirus (CMV Ad. 169)-induced late antigens are specifically inhibited by phosphonoformate (PFA). Four fresh isolates of CMV were also inhibited by PFA to varying degrees. The kinetics of CMV immediate early antigens (IEA) and early nuclear antigens (EA) produced in the presence of PFA were compared to the early phase of the replicative infection. After anticomplement immunofluorescence with anti-IEA and anti-EA, microimmunofluorometry of individual CMV-infected nuclei was performed. CMV-induced antigens had a two-wave appearance, with maxima at 6 and 24 h postinfection. The same was seen in the presence of PFA. CMV EA-containing cells persisted for more than 5 weeks in the presence of PFA, but decreased in frequency and antigen content. The inhibition of virus replication was reversible after all incubation periods assayed. After PFA release, IEA and EA appeared again in many cells, and the kinetics were similar to that of initial infection. The results suggest that the input CMV genome persists in most initially infected cells, survives PFA incubation, and is active again after PFA release. This differs from abortive CMV infections.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6259084     DOI: 10.1159/000149156

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  17 in total

Review 1.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Activity of the cytomegalovirus genome in the presence of PPi analogs.

Authors:  B Wahren; U Rudén; H Gadler; B Oberg; B Eriksson
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  Identification and characterization of a major early cytomegalovirus DNA-binding protein.

Authors:  D G Anders; A Irmiere; W Gibson
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Early interactions between human cytomegalovirus and cells.

Authors:  B Wahren; L Einhorn; H Gadler
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

5.  Association between virus and cell DNA during latent cytomegalovirus infection in vitro.

Authors:  H Gadler; B Wahren
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.

Authors:  G Abele; A Karlström; J Harmenberg; S Shigeta; A Larsson; B Lindborg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

7.  D,L-alpha-difluoromethylornithine inhibits human cytomegalovirus replication.

Authors:  W Gibson; R van Breemen; A Fields; R LaFemina; A Irmiere
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Penetration of foscarnet into cerebrospinal fluid of AIDS patients.

Authors:  F Raffi; A M Taburet; B Ghaleh; A Huart; E Singlas
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis.

Authors:  U R Hengge; N H Brockmeyer; R Malessa; U Ravens; M Goos
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 10.  Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.

Authors:  C U Tuazon; A M Labriola
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.